|
[1]Hawkes RA.Enhancement of the infectivity of arboviruses by spe-cific antisera produced in domestic fowls[J].Aust J Exp Biol MedSci, 1964, 42:465-482.
|
|
[2]Tirado, SM, Yoon KJ.Antibody-dependent enhancement of virusinfection and disease[J].Viral Immunol, 2003, 16 (1) :69-86.
|
|
[3]Mori S, Takeuchi T, Kanda T.Antibody-enhancement of adeno-associated virus infection of human monocytic cell lines[J].Virolo-gy, 2008, 375 (1) :141-147.
|
|
[4]Halstead SB, Shotwell H, Casals J.Studies on the pathogenesis ofdengue infection in monkeys.Ⅱ.Clinical laboratory responses toheterologous infection[J].Infect Dis, 1973, 128 (1) :15-22.
|
|
[5]Lavillette D, Morice Y, Germanidis G.Human serum facilitateshepatitis C virus infection, and neutralizing responses inversely cor-relate with viral replication kinetics at the acute phase of hepatitis Cvirus infection[J].Virol, 2005, 79 (10) :6023-6034.
|
|
[6]Meunier JC, Engle RE, Faulk K, et al.Evidence for cross-geno-type neutralization of hepatitis C virus pseudo-particles and en-hancement of infectivity by apolipoprotein C1[J].Proc Natl AcadSci USA, 2005, 102 (12) :4560-4565.
|
|
[7]Munakata Y, Kato I, Saito T, et al.Human parvovirus B19 infec-tion of monocytic cell line U937 and antibody-dependent enhance-ment[J].Virology, 2006, 345 (1) :251-257.
|
|
[8]Huanq KJ, Yang YC, Lin YS, et al.The dual-special binding ofdengue virus and target cells for the antibody dependent enhance-ment of dengue virus infection[J].Immunl, 2006, 176 (5) :2825-2832.
|
|
[9]Takada A, Kawaoka Y.Antibody-dependent enhancement of viralinfection:molecular mechanisms and in vivo implications[J].RevMed Virol, 2003, 13 (6) :387-98.
|
|
[10]Burton DR, Saphire EQ, Parren PW.A model for neutralizationofviruses based on antibody coating of the virion surface[J].Curr TopMicrobiol Immunol, 2001, 60 (2) :109-143.
|
|
[11]Mori S, Takeuchi T, Kanda T.Antibody-enhancement of adeno-associated virus infection of human monocytic cell lines[J].Virolo-gy, 2008, 375 (1) :141-147.
|
|
[12]Bartosch B, Dubuisson J, Cosset FL.Infectious hepatitis C viruspseudo-particles containing functional E1-E2 envelope proteincomplexes[J].Exp Med, 2003, 197 (5) :633-642.
|
|
[13]Basu A, Kanda T, Beyene A, et al.Sulfated homologues of heparininhibit hepatitis C virus entry into mammalian cells[J].Virol, 2007, 81 (8) :3933-3941.
|
|
[14]Hadlock KG, Lanford RE, Perkins S, et al.Human monoclonal an-tibodies that inhibit binding of hepatitis C virus E2 protein to CD81and recognize conserved conformational epitopes[J].Virol, 2000, 74 (22) :10407-10416.
|
|
[15]Kanda T, Basu A, Steele R, Generation of infectious hepatitis C vi-rus in immortalized human hepatocytes[J].Virol, 2006, 80 (9) :4633-4639.
|
|
[16]Cao J, Chen ZH, Ren YL, et al.Oral immunization with attenuatedSalmonella carrying a co-expression plasmid encoding the core andE2 proteins of hepatitis C virus capable of inducing cellular immuneresponses and neutralizing antibodies in mice[J].Vaccine, 2011, 29 (20) :3714-3723.
|
|
[17]Toth FD, Mosborg-Petersen P, Kiss J, et al.Antibody-depend-ent enhancement of HIV-1 infection in human term syncytiotropho-blast cells cultured in vitro[J].Clin Exp Immunol.1994, 96 (3) :389-394.
|
|
[18]聂青和, 罗新栋, 张亚飞, 等.HCV感染人滋养层细胞过程中抗体依赖性增强作用的初步研究[J].胃肠病学和肝病学杂志, 2006, 15 (4) :379-382.
|
|
[19]Meyer K, Ait-Goughoulte M, Keck ZY, et al.Antibody-de-pendent enhancement of hepatitis C virus infection[J].J Virol, 2008, 82 (5) :2140-2149.
|
|
[20]Nicholson CO, Costin JM, Rowe DK, et al.Viral entry inhibitorsblock dengue antibody-dependent enhancement in vitro[J].Anti-viral Research, 2011, 89 (1) :71-74.
|
DownLoad: